ARCT-2138
ARCT-2138-01
Phase 1 mab completed
Quick answer
ARCT-2138 for Influenza, Human is a Phase 1 program (mab) at Arcturus Therapeutics Holdings with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Arcturus Therapeutics Holdings
- Indication
- Influenza, Human
- Phase
- Phase 1
- Modality
- mab
- Status
- completed